|
PCMTD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6251444634463E-12 |
| Normal-vs-Stage2 |
2.53059999955063E-07 |
| Normal-vs-Stage3 |
1.95399252334028E-14 |
| Normal-vs-Stage4 |
1.66723999999174E-05 |
| Stage1-vs-Stage2 |
2.564200E-01 |
| Stage1-vs-Stage3 |
4.123400E-01 |
| Stage1-vs-Stage4 |
5.799400E-01 |
| Stage2-vs-Stage3 |
1.323580E-01 |
| Stage2-vs-Stage4 |
8.163600E-01 |
| Stage3-vs-Stage4 |
4.278000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.80599987689811E-11 |
| Normal-vs-Asian |
3.60470000004831E-06 |
| Caucasian-vs-AfricanAmerican |
4.715600E-01 |
| Caucasian-vs-Asian |
9.017600E-01 |
| AfricanAmerican-vs-Asian |
7.242800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
7.92454990516944E-12 |
| Male-vs-Female |
1.240180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.40459865960452E-11 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
5.13589171191597E-13 |
| Normal-vs-Extreme_Obese |
5.87299999965651E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.855800E-01 |
| Normal_Weight-vs-Obese |
6.347600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.693000E-01 |
| Extreme_Weight-vs-Obese |
9.983600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.570400E-01 |
| Obese-vs-Extreme_Obese |
9.142000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.15450000021711E-07 |
| Normal-vs-Age(41-60Yrs) |
4.66293670342566E-15 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
6.8023031651876E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.815400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.371990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.192200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.324420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.098100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.412600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
5.56221735337203E-14 |
| Normal-VS-KIRP CIMP |
3.05279999945895E-07 |
| Normal-VS-Unclassified PRCC |
6.40219999237246E-09 |
| Type1 PRCC-VS-Type2 PRCC |
7.788800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.594400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.761800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.764800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.330600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.372000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
1.37500000052526E-07 |
| Normal-vs-N2 |
6.23789999999458E-05 |
| N0-vs-N1 |
1.080200E-01 |
| N0-vs-N2 |
4.422800E-01 |
| N1-vs-N2 |
2.329800E-01 |
|
|
